10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001121781-16-000515`
Period End Date	20160630
Filing Date	20160817
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	gthp-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 84 Cash Flow Statement 68

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$95.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$78.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.97M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$140.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$118.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $78 and $95 at June 30, 2016 and December 31, 2015, respectively	`AccountsReceivableNet`	$289.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $78 and $95 at June 30, 2016 and December 31, 2015, respectively	`AccountsReceivableNet`	$190.00K	USD	Point-in-time
Inventory, net of reserves of $140 and $118, at June 30, 2016 and December 31, 2015, respectively	`InventoryNet`	$1.12M	USD	Point-in-time
Inventory, net of reserves of $140 and $118, at June 30, 2016 and December 31, 2015, respectively	`InventoryNet`	$1.24M	USD	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseAndOtherAssets`	$502.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Prepaid expenses and deposits	`PrepaidExpenseAndOtherAssets`	$780.00K	USD	Point-in-time
Series C convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC`	$0.00	USD	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Series C convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC`	9.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.12M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$217.00K	USD	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	2.10	shares	Point-in-time
Series C convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC`	5.60	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$318.00K	USD	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	5.60	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$45.00K	USD	Point-in-time
Series C convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC`	2.10	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$121.00K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$5.55K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$439.00K	USD	Point-in-time
Series C convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreference`	$5.55K	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$262.00K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.56M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.31M	USD	Point-in-time
Series C1 convertible preferred stock par value	`PreferredStockParOrStatedValuePerShareSeriesC1`	$0.00	USD	Point-in-time
Series C1 convertible preferred stock shares authorized	`PreferredStockSharesAuthorizedSeriesC1`	20.30	shares	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$532.00K	USD	Point-in-time
Series C1 convertible preferred stock, Issued	`PreferredStockSharesIssuedSeriesC1`	4.30	shares	Point-in-time
Short-term notes payable, including related parties	`ShorttermNotesPayable`	$752.00K	USD	Point-in-time
Series C1 convertible preferred stock, Outstanding	`PreferredStockSharesOutstandingSeriesC1`	4.30	shares	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$596.00K	USD	Point-in-time
Note payable in default, including related parties	`NotePayableInDefault`	$133.00K	USD	Point-in-time
Convertible note current portion	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible note current portion	`ConvertibleNotesPayableCurrent`	$1.83M	USD	Point-in-time
Series C1 convertible preferred stock, Liquidation preference	`PreferredStockLiquidationPreferenceC1`	$4.31K	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$602.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Short-term convertible notes payable, net	`NotesAndLoansPayableCurrent`	$686.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.21M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.82M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	1.00M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.91M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$2.15M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	2,371.00	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	84,952.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	84,952.00	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	2,371.00	shares	Point-in-time
Deferred revenue	`DeferredRevenue`	$217.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$41.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.52M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.96M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$2.61M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$1.49M	USD	Point-in-time
Long-term convertible notes payable, net	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$8.12M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$9.45M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 5.0 and 5.6 shares issued and outstanding as of March 31, 2016 and December 31, 2015, (Liquidation preference of $4,966 and $5,555 at March 31, 2016 and December 31, 2015)	`SeriesCPreferredStock`	$2.05M	USD	Point-in-time
Series C convertible preferred stock, $.001 par value; 9.0 shares authorized, 5.0 and 5.6 shares issued and outstanding as of March 31, 2016 and December 31, 2015, (Liquidation preference of $4,966 and $5,555 at March 31, 2016 and December 31, 2015)	`SeriesCPreferredStock`	$801.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of June 30, 2016 (Liquidation preference of $4,312 at June 30, 2016)	`SeriesC1PreferredStock`	$701.00K	USD	Point-in-time
Series C1 convertible preferred stock, $.001 par value; 20.3 shares authorized, 4.3 shares issued and outstanding as of June 30, 2016 (Liquidation preference of $4,312 at June 30, 2016)	`SeriesC1PreferredStock`	-	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 5,322 and 2,371 shares issued and outstanding as of March, 31 2016 and December 31, 2015	`CommonStockValue`	$376.00K	USD	Point-in-time
Common stock, $.001 Par value; 1,000,000 shares authorized, 5,322 and 2,371 shares issued and outstanding as of March, 31 2016 and December 31, 2015	`CommonStockValue`	$236.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$114.84M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$116.19M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-122.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-125.07M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-5.56M	USD	Point-in-time
TOTAL STOCKHOLDERS' DEFICIT	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.14M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.56M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.31M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Sales - devices and disposables	`SalesDevicesAndDisposables`	$129.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$103.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$391.00K	USD	2 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$229.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$33.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$314.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$207.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$101.00K	USD	2 Qtrs
Gross profit (loss)	`GrossProfit`	$-85.00K	USD	2 Qtrs
Gross profit (loss)	`GrossProfit`	$-104.00K	USD	1 Quarter
Gross profit (loss)	`GrossProfit`	$96.00K	USD	1 Quarter
Gross profit (loss)	`GrossProfit`	$290.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$305.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$148.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$438.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$677.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$203.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$355.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$183.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$86.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.68M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$760.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.02M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.98M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$3.01M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$994.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.51M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.32M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.60M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.07M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-898.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.03M	USD	2 Qtrs
Other income	`OtherIncome`	$44.00K	USD	2 Qtrs
Other income	`OtherIncome`	$21.00K	USD	1 Quarter
Other income	`OtherIncome`	$284.00K	USD	1 Quarter
Other income	`OtherIncome`	$290.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$323.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$815.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.21M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.37M	USD	2 Qtrs
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$1.61M	USD	2 Qtrs
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$211.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$-66.00K	USD	1 Quarter
Changes in fair value of warrants	`DerivativeGainLossOnDerivativeNet`	$648.00K	USD	2 Qtrs
Total other income	`OtherNonoperatingIncome`	$-105.00K	USD	1 Quarter
Total other income	`OtherNonoperatingIncome`	$123.00K	USD	2 Qtrs
Total other income	`OtherNonoperatingIncome`	$279.00K	USD	2 Qtrs
Total other income	`OtherNonoperatingIncome`	$-981.00K	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.75M	USD	2 Qtrs
INCOME (LOSS) FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.95M	USD	2 Qtrs
INCOME (LOSS) FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.88M	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.71M	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-2.95M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.75M	USD	2 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.88M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.71M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.29M	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.33M	USD	2 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-292.00K	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-762.00K	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.28M	USD	2 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.00M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.17M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.51M	USD	2 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, BASIC	`EarningsPerShareBasic`	$-0.14	USD	2 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, BASIC	`EarningsPerShareBasic`	$-0.04	USD	2 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, BASIC	`EarningsPerShareBasic`	$-0.03	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, BASIC	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, DILUTED	`EarningsPerShareDiluted`	$-0.04	USD	2 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, DILUTED	`EarningsPerShareDiluted`	$-0.14	USD	2 Qtrs
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, DILUTED	`EarningsPerShareDiluted`	$-0.03	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS, DILUTED	`EarningsPerShareDiluted`	$-0.07	USD	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	17,875.00	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	32,666.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	107,256.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC	`WeightedAverageNumberOfSharesOutstandingBasic`	102,326.00	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING, DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	107,256.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	32,666.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING, DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	17,875.00	shares	2 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING, DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	102,326.00	shares	2 Qtrs

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-2.95M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.75M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.88M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-1.71M	USD	1 Quarter
Bad debt expense	`BadDebtExpense`	-	USD	2 Qtrs
Bad debt expense	`BadDebtExpense`	$20.00K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$102.00K	USD	2 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$144.00K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$816.00K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$543.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$529.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$53.00K	USD	2 Qtrs
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$648.00K	USD	2 Qtrs
Change in fair value of warrants	`ChangeInFairValueOfWarrants`	$1.61M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-194.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$120.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-56.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$119.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-73.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-280.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-10.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-27.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$231.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$384.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-176.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$12.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$549.00K	USD	2 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$613.00K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$210.00K	USD	2 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.76M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.54M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-1.19M	USD	2 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	2 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.03M	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	-	USD	2 Qtrs
Net proceeds from issuance of common stock and warrants, net	`ProceedsFromRepurchaseOfEquity`	$720.00K	USD	2 Qtrs
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$1.62M	USD	2 Qtrs
Proceeds from debt financing, net of discounts and debt issuance costs	`ProceedsFromIssuanceOfLongTermDebt`	$203.00K	USD	2 Qtrs
Payments on notes payable	`PaymentsOfLoanCosts`	$92.00K	USD	2 Qtrs
Payments on notes payable	`PaymentsOfLoanCosts`	$91.00K	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$141.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.01M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.53M	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.81M	USD	2 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-13.00K	USD	2 Qtrs
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.97M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$22.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$162.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.97M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$22.00K	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$1.00K	USD	2 Qtrs
Cash paid for Interest	`InterestPaid`	$56.00K	USD	2 Qtrs
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	-	USD	2 Qtrs
Deemed dividend on beneficial conversion feature of Series C preferred stock	`DeemedDividendOnBeneficialConversionFeatureOfSeriesCPreferredStock`	$148.00K	USD	2 Qtrs
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	-	USD	2 Qtrs
Deemed dividend on price changes for Series B preferred stock warrants	`DeemedDividendOnPriceChangesForSeriesBPreferredStockWarrants`	$72.00K	USD	2 Qtrs
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$833.00K	USD	2 Qtrs
Issuance of common stock as debt repayment	`IssuanceOfCommonStockAsDebtRepayment`	$225.00K	USD	2 Qtrs
Dividends on preferred stock	`DividendsOnPreferredStock`	$762.00K	USD	2 Qtrs
Dividends on preferred stock	`DividendsOnPreferredStock`	$64.00K	USD	2 Qtrs
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnPublicOfferingWarrants`	$1.04M	USD	2 Qtrs
Deemed dividend on December 2014 public offering warrants	`DeemedDividendOnPublicOfferingWarrants`	-	USD	2 Qtrs
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockaNDOfferingWarrantsResultingInTransferToEquity`	$1.41M	USD	2 Qtrs
Term changes on Series B preferred stock and December 2014 public offering warrants resulting in transfer to equity	`TermChangesOnSeriesBPreferredStockaNDOfferingWarrantsResultingInTransferToEquity`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.